“I don’t think this is a cure. I don’t think this is going to be the one drug answer to this disease,” Dr. Scott Gottlieb said today about Gilead’s Remdesivir. “But it can change the contours of the disease.”
The report from the Chicago hospital comes amid mounting anecdotal evidence supporting the drug's potential effectiveness in treating the virus. Last week, the New England Journal of Medicine published an analysis showing that two thirds of a small group of severely ill patients saw their condition improve after taking the drug.
The information reported by STAT News came from an internal discussion among faculty members at a University of Chicago hospital captured on video, it was not official data released by Gilead or any other trial leader.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Market Is Overreacting to Gilead’s Coronavirus Drug Remdesivir, Analysts SayThe major U.S. stock indexes took off in response to a report about the drug on Thursday evening.
Read more »
Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI.
Read more »
Gilead increases enrollment target for remdesivir trial in COVID-19 patientsGilead Sciences Inc on Friday increased enrollment target by 3,600 for a trial testing its experimental drug, remdesivir, in severe COVID-19 patients, a day after a media report said the drug was showing promise.
Read more »
A treatment for the coronavirus would be priceless — and worth about 5,000 points in the Dow Jones Industrial Average'The stock market bulls’ declaration of victory on anecdotal data about Gilead’s remdesivir treatment is premature,' says TheAroraReport. But 'the stock market’s reaction shows that a 5,000 Dow point rally is highly probable if a true cure is found.'
Read more »
Gilead Stock Jumps 8% After Coronavirus Drug Remdesivir Shows ‘Rapid Recoveries’ In Clinical TrialsShares of biotech company Gilead Sciences, which has been at the forefront of developing a treatment for COVID-19 patients, surged today after a report that a clinical trial for its antiviral drug, Remdesivir, was showing successful results by skleb1234
Read more »
Stock market live updates: Rally losing steam, Gilead surges, Amazon dropsSeveral pharmaceutical and medical stocks like $ABT and $VRTX hit new highs today. Follow along with the latest stock market updates here:
Read more »